Lavixe works by inhibiting key inflammatory cytokines such as TNF-α, IL-4, and IL-1β-cytokines that play a central role in skin inflammation. In comparative studies, it has shown comparable cytokine inhibition versus topical corticosteroids. Additionally, Lavixe helps reduce mast cell infiltration, which contributes to the reduction of histamine-related itch and allergic responses. Clinically tested, Lavixe is proven to visibly reduce redness and itching within just 30 minutes of application. Its mode of action is safer than steroids, making it suitable for sensitive skin and long-term use without the risk of skin thinning or barrier damage.